triazolam has been researched along with Narcosis in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Narcosis: A state of depressed CENTRAL NERVOUS SYSTEM marked by stupor or insensibility.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stupor is a diagnostic challenge at emergency department." | 1.48 | Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor. ( Antelmi, E; Busardò, FP; Moresco, M; Pichini, S; Pizza, F; Plazzi, G; Postiglione, E, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Postiglione, E | 1 |
| Antelmi, E | 1 |
| Moresco, M | 1 |
| Pichini, S | 1 |
| Pizza, F | 1 |
| Plazzi, G | 1 |
| Busardò, FP | 1 |
1 other study available for triazolam and Narcosis
| Article | Year |
|---|---|
Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor.
Topics: Adult; Hair; Humans; Male; Recurrence; Stupor; Substance-Related Disorders; Time Factors; Triazolam | 2018 |